Activeted-370198-2026
Active Ingredients for CAR-T Cell Therapies for Patients of ULSS N. 8 Berica
Tender for the supply of active ingredients for CAR-T cell therapies. These innovative treatments are intended for adult patients with various types of lymphoma under the care of Azienda ULSS N. 8 Berica.
€15,936,345
View original sourceCONTRACTING AUTHORITY
Name
AZIENDA ULSS N. 8 BERICA
City
VICENZA
Country
IT
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33652000, Antineoplastic and immunomodulating agents.
LOTS (3)
LOT-0001Supplies
CAR-T-Therapie für DLBCL-Patienten (2. & 3. Linie)
€15,936,345
LOT-0002Supplies
CAR-T-Therapie für DLBCL-Patienten (3. Linie)
€1,732,800
LOT-0003Supplies
CAR-T-Therapie für follikuläre Lymphom-Patienten (4. Linie)
€1,732,800
ADDITIONAL DETAILS
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
26 days remaining(LOT-0001)
Published